Acadia Pharmaceuticals Inc

Vanguard Personalized Indexing Management, LLC ACAD
Report date
12/31/2025
Quarter
2025 Q4
Filed
2/13/2026
Shares
7,812
Value ($000)
209
Weight
0.0%
2024 Q4 - 2025 Q4 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).